Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Crispr Therapeutics Ag
(NQ:
CRSP
)
51.17
-2.38 (-4.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Crispr Therapeutics Ag
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
26
27
Next >
Cathie Wood Just Bought More CRISPR Therapeutics (CRSP) Stock
April 13, 2023
Shares of CRSP stock are moving higher following an initiation of coverage by Cantor Fitzgerald and continued buys from Cathie Wood.
Via
InvestorPlace
Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today?
April 13, 2023
While CRSPR stock captured the spotlight for potentially encouraging drug data, the news lifted other gene-editing stocks.
Via
InvestorPlace
CRISPR Therapeutics Is an Interesting 'Gene Editing Play for 2023' With Significant Upside, Says Analyst
April 13, 2023
Via
Benzinga
$2M Price Tag for Sickle Cell Gene Therapies Could Be Cost-Effective Under Certain Scenarios, Finds ICER Analysis
April 13, 2023
Via
Benzinga
Why Shares of CRISPR Therapeutics Jumped Thursday
April 13, 2023
An independent drug-pricing group said that a $1.9 million cost for the company's exa-cel therapy would be cost-effective.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023
April 13, 2023
Via
Benzinga
Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday
April 13, 2023
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
2 Nasdaq Growth Stocks That Are Screaming Buys in April
April 13, 2023
Massive drivers of fresh earnings are drawing closer, and risks are declining.
Via
The Motley Fool
These Up-and-Coming Stocks Are Screaming Buys Right Now
April 13, 2023
Both companies could deliver revenue and share price growth over the long term.
Via
The Motley Fool
Could This Move Make Vertex's Next Blockbuster Even Bigger?
April 12, 2023
Vertex is showing it can branch out beyond its cystic fibrosis specialty.
Via
The Motley Fool
Cryoport Supports Clinical Trials And Commercial Therapies Across The High-Growth BioTech Industry: Is Its Current Stock Price An Opportunity?
April 10, 2023
The global biotechnology industry was worth $859 billion in 2022, and it is predicted to reach $1.6 trillion by 2030, growing at a compound annual growth rate (CAGR) of 8.7% over the forecast period.
Via
Benzinga
Where Will CRISPR Therapeutics Be in 5 Years?
April 09, 2023
Could CRISPR Therapeutics be the next big healthcare stock?
Via
The Motley Fool
CRISPR Stock: Bull vs. Bear
April 08, 2023
CRISPR's first approved product may be right around the corner.
Via
The Motley Fool
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
April 07, 2023
Medical stocks are holding up amid economic and market uncertainty.
Via
Investor's Business Daily
What's the Better Dip to Buy: CRISPR Therapeutics vs. Bluebird Bio
April 06, 2023
Both biotechs are aiming for the same markets, but they are not equally risky.
Via
The Motley Fool
Better Gene-Editing Stock: Editas Medicine vs. Bluebird Bio
April 06, 2023
Neither stock is a good choice for those who can't handle a lot of risk.
Via
The Motley Fool
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global
April 06, 2023
Via
Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2023
April 05, 2023
Both companies have game-changing product portfolios that should result in stock price growth.
Via
The Motley Fool
Why Bluebird Bio Shares Are Plunging Today
March 29, 2023
Via
Benzinga
Could This Stock Become the Tesla of Its Industry?
March 25, 2023
It's in a race to a multi-billion dollar market.
Via
The Motley Fool
Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?
April 04, 2023
Vertex shares are on the rise.
Via
The Motley Fool
The 10 Best Stocks to Buy in April 2023
April 01, 2023
Here are 10 stocks to buy now that could unlock explosive gains in your growth-stock portfolio.
Via
The Motley Fool
Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics
April 01, 2023
Together, the companies could produce a game-changing product.
Via
The Motley Fool
5 Bargain-Basement Stocks to Buy Right Now
March 31, 2023
Down markets offer us something very positive: deals on quality companies.
Via
The Motley Fool
The 3 Best Growth Stocks to Buy in the Biotech Sector
March 29, 2023
These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors.
Via
InvestorPlace
7 Biotech Stocks to Buy for Breakthrough Treatments and Cures
March 29, 2023
For those that can handle the heat, these biotech stocks to buy undergird some of the most powerful innovations in medicine.
Via
InvestorPlace
Could CRISPR Therapeutics Become the Next Moderna?
March 27, 2023
Both companies use cutting-edge technology.
Via
The Motley Fool
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
March 25, 2023
Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it.
Via
InvestorPlace
3 Simple Ways to Supercharge Your Biopharma Investing Using Artificial Intelligence
March 24, 2023
Your stock screening and research process will never be the same.
Via
The Motley Fool
This Cathie Wood Stock Could Nearly Double, According to Wall Street
March 23, 2023
If the stock market continues to rally, this biotech could benefit.
Via
The Motley Fool
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.